Status | Study |
Recruiting |
Study Name: Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months Condition: Meningitis, Meningococcal Date: 2016-08-22 Interventions: Biological: Meningococcal ACYW135 Polysaccharide Conjugate Vaccine |
Recruiting |
Study Name: Ciprofloxacin for the Prevention of Meningococcal Meningitis Condition: Meningitis, Meningococcal Date: 2016-03-15 Interventions: Drug: Ciprofloxacin Single-dose oral ciprofloxacin O |
Recruiting |
Study Name: A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine Condition: Meningococcal Meningitis Date: 2015-06-23 Interventions: Biological: freeze-dried group ACYW135 MCV Group A, C, Y and W135 Meningococcal conjugate vaccine is sui |
Completed |
Study Name: Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ. Condition: Meningitis, Meningococcal, Serogroup B Date: 2014-11-20 Interventions: Biological: Meningococcal (group B) multicomponent recombinant adsorbed vaccine One dose (0.5 mL) vaccin |
Completed |
Study Name: Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos Condition: Meningitis, Meningococcal, Serogroup C Date: 2013-06-10 Interventions: Biological: 'MenCC-Bio' The ex |
Completed |
Study Name: Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age Condition: Meningitis, Meningococcal, Serogroup B Date: 2013-01-08 Interventions: Biological: rLP2086 0.5 ml intramuscular injection of 120 microgram bivalent rLP2085 administered at 0, |
Completed |
Study Name: A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents Condition: Meningococcal Meningitis Date: 2011-08-23 Interventions: Biological: Placebo + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular |
Completed |
Study Name: A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years Condition: Meningitis, Meningococcal Date: 2011-05-11 Interventions: Biological: rLP2086 vaccine 12 |
Completed |
Study Name: Comparison of Two Meningococcal ACWY Conjugate Vaccines Condition: Meningococcal Meningitis Date: 2010-08-31 Interventions: Biological: Menveo Single dose |
Completed |
Study Name: Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine Condition: Meningococcal Meningitis Date: 2010-06-16 Interventions: Biological: Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine |